LPL Financial
ONCY icon

LPL Financial’s Oncolytics Biotech ONCY Stock Holding History

LPL Financial’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$49.9K Sell
74,746
-5,570
-7% -$4.52K ﹤0.01% 6121
2026
Q2 		$76.3K Buy
80,316
+1,415
+2% +$1.31K ﹤0.01% 5960
2026
Q1 		$67K Buy
78,901
+38,483
+95% +$38.3K ﹤0.01% 5745
2025
Q4 		$35.3K Sell
40,418
-10,937
-21% -$11.8K ﹤0.01% 5742
2025
Q3 		$71.9K Buy
+51,355
New +$57.5K ﹤0.01% 5578
2025
Q2 		– Sell
-16,150
Closed -$8.88K – 5656
2025
Q1 		$8.88K Buy
16,150
+128
+0.8% +$94 ﹤0.01% 5321
2024
Q4 		$14.6K Sell
16,022
-4,500
-22% -$4.68K ﹤0.01% 5230
2024
Q3 		$17.9K Buy
20,522
+13
+0.1% +$13 ﹤0.01% 5093
2024
Q2 		$20.3K Buy
20,509
+2,500
+14% +$2.72K ﹤0.01% 4934
2024
Q1 		$19.1K Sell
18,009
-1,570
-8% -$1.75K ﹤0.01% 4846
2023
Q4 		$26.4K Sell
19,579
-2,000
-9% -$3.13K ﹤0.01% 4716
2023
Q3 		$47K Buy
+21,579
New +$52.7K ﹤0.01% 4525
2022
Q4 		– Sell
-16,512
Closed -$20K – 4528
2022
Q3 		$20K Hold
16,512
– – ﹤0.01% 4328
2022
Q2 		$17K Sell
16,512
-5,000
-23% -$6.08K ﹤0.01% 4353
2022
Q1 		$34K Buy
21,512
+1,000
+5% +$1.68K ﹤0.01% 4086
2021
Q4 		$29K Buy
20,512
+23
+0.1% +$43 ﹤0.01% 4271
2021
Q3 		$43K Buy
20,489
+8,529
+71% +$19.3K ﹤0.01% 4239
2021
Q2 		$33K Sell
11,960
-550
-4% -$1.68K ﹤0.01% 4171
2021
Q1 		$48K Buy
12,510
+1,000
+9% +$2.98K ﹤0.01% 3998
2020
Q4 		$27K Sell
11,510
-2,000
-15% -$4.79K ﹤0.01% 3769
2020
Q3 		$23K Hold
13,510
– – ﹤0.01% 3497
2020
Q2 		$25K Buy
+13,510
New +$25.4K ﹤0.01% 3397

Other funds holding ONCY

IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 22.25% 1-Year Est. Return
Larson Financial Group
Larson Financial Group St Louis, Missouri $4.11B AUM 23.62% 1-Year Est. Return
Everhart Financial Group
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Doliver Advisors
Doliver Advisors Houston, Texas $458M AUM 38.24% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return
Badgley Phelps Wealth Managers
Badgley Phelps Wealth Managers Seattle, Washington $5.8B AUM 25.34% 1-Year Est. Return
Clearstead Advisors
Clearstead Advisors Cleveland, Ohio $10.8B AUM 17.88% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.25% 1-Year Est. Return

LPL Financial's ONCY Position: Q3 2026 in Review

LPL Financial reduced its Oncolytics Biotech (ONCY) stake by 6.9% in Q3 2026, selling an estimated $4.52K and leaving 74,746 shares worth $49.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6121.

LPL Financial first reported a position in ONCY in Q2 2020 and has held it in 22 quarters since. The position peaked at $76.3K in Q2 2026. 33 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.

  • LPL Financial held 74,746 shares of Oncolytics Biotech worth $49.9K as of Q3 2026.
  • LPL Financial sold 5,570 Oncolytics Biotech shares in Q3 2026, an estimated $4.52K.
  • Oncolytics Biotech made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #6121 holding.
  • LPL Financial first reported a position in Oncolytics Biotech in Q2 2020 and has held it in 22 quarters since.
  • LPL Financial's Oncolytics Biotech position peaked at $76.3K in Q2 2026.
  • 33 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.